| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ea2562ffa41a54fc6a83ccf31f302d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0229206c7c1a06c492c07518b39a47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3467587e88ec67560449b5479323d995 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate |
2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1cd53dc3b3d29746d0b1dafb82596d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4f5d391c650b8b81904a2e3e5e2b26 |
| publicationDate |
2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0240052-A1 |
| titleOfInvention |
Inhalation of nitric oxide |
| abstract |
Use of inhalable gaseous nitric oxide (NO) in combination with a cyclooxygenase inhibitor for the manufacture of a medicament for treating pulmonary vasoconstriction or airway constriction in a mammal, including man, in order to counteract a hypo- or non- response to treatment with gaseous nitric oxide or nitric oxide donor only and/or to counteract a rebound response in the case of withdrawal of treatment with gaseous nitric oxide or nitric oxide donor only said combination being use in a therapeutically effective amount to accomplish relaxation of said pulmonary vasoconstriction or airway constriction. A method and a pharmaceutical preparation for the treatment of pulmonary vasoconstriction or airway constriction while using the above-mentioned combination. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004045533-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1400243-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014352-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7049326-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7164027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014352-A3 |
| priorityDate |
2000-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |